13F-HR filed by Tri Locum Partners LP
Tri Locum Partners LP filed this 13F-HR for the quarter ended 2026-03-31, filed 2026-05-18, with 17 holding rows worth $712,549,412.
- Accession
- 0001826434-26-000004
- Filer
- CIK 1826434
- Filed
- 2026-05-18
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2026
A holdings report, 17 entries on the cover page, a total value of $712,549,412 stated on the cover page (in dollars after the unit check, H1), rows summing to $712,549,412 with VALUE read as dollars as filed, 13F file number 028-21000. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Johnson & Johnson | 478160104 | COM | 414,503 | $101,321,113 | dollars as filed | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 153,250 | $70,646,718 | dollars as filed | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 132,413 | $65,084,962 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 255,332 | $58,402,088 | dollars as filed | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 129,314 | $57,743,874 | dollars as filed | |
| Eli Lilly and Company | 532457108 | COM | 61,795 | $56,837,187 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 103,288 | $54,068,169 | dollars as filed | |
| DEXCOM INC COM | 252131107 | Stock | 698,158 | $43,844,322 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 70,370 | $41,728,003 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 308,506 | $31,606,440 | dollars as filed | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 1,021,008 | $30,752,761 | dollars as filed | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 158,663 | $29,995,240 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 31,635 | $23,101,459 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 252,588 | $17,719,048 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 145,543 | $12,213,969 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 62,116 | $10,498,846 | dollars as filed | |
| DEFINIUM THERAPEUTICS INC | 24477V105 | COM SHS | 369,588 | $6,985,213 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001826434-26-000004 | this filing | 2026-05-18 | acceptance time not in the bulk data set |